Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M200Revenue $M7.2Net Margin (%)-1,486.9Z-Score-1.1
Enterprise Value $M42.5EPS $-1.0Operating Margin %-1,492.6F-Score4
P/E(ttm))0Cash Flow Per Share $-1.2Pre-tax Margin (%)-1,486.9Higher ROA y-yY
Price/Book1.410-y EBITDA Growth Rate %0Quick Ratio15.6Cash flow > EarningsY
Price/Sales32.65-y EBITDA Growth Rate %0Current Ratio15.6Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-42.1Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-45.8Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M87.8ROI % (ttm)-45.0Gross Margin Increase y-yN

Gurus Latest Trades with RIGL

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
RIGLCharles Brandes 2014-09-30 Sold Out $1.97 - $3.84
($2.81)
$ 2.28-19%Sold Out0
RIGLCharles Brandes 2014-03-31 Buy $2.7 - $4.75
($3.53)
$ 2.28-35%New holding, 15000 sh.15,000
RIGLGeorge Soros 2011-12-31 Sold Out -0.0019%$6.68 - $8.3
($7.59)
$ 2.28-70%Sold Out0
RIGLGeorge Soros 2011-06-30 Buy $7.18 - $9.19
($8.08)
$ 2.28-72%New holding, 14500 sh.14,500
RIGLJean-Marie Eveillard 2011-06-30 Sold Out $7.18 - $9.19
($8.08)
$ 2.28-72%Sold Out0
RIGLJean-Marie Eveillard 2011-03-31 Buy $6.54 - $7.74
($7.06)
$ 2.28-68%New holding, 46700 sh.46,700
RIGLGeorge Soros 2010-09-30 Sold Out $6.94 - $8.8
($8.11)
$ 2.28-72%Sold Out0
RIGLGeorge Soros 2010-03-31 Add$7.41 - $9.83
($8.55)
$ 2.28-73%Add 34.29%14,100
RIGLGeorge Soros 2009-12-31 Buy $6.08 - $9.86
($7.86)
$ 2.28-71%New holding, 10500 sh.10,500
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

RIGL is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
RIGL Charles Brandes 2014-09-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


RIGL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
PAYAN DONALD GEVP, Pres. Discovery&Research 2014-09-03Sell20,000$2.56-21.09view
PAYAN DONALD GEVP, Pres. Discovery&Research 2014-02-24Sell20,000$3.71-45.55view
BVF PARTNERS L P/IL10% Owner 2013-11-19Sell484,622$2.64-23.48view
BVF PARTNERS L P/IL10% Owner 2013-06-07Buy32,700$3.47-41.79view
VANCE DOLLYEVP Corp. Affairs, G.C., Sect. 2012-09-13Sell4,151$10.43-80.63view
Maynard Ryan DEVP & CFO 2012-09-12Sell23,302$10.67-81.07view
Maynard Ryan DEVP & CFO 2012-09-10Sell51,698$10.54-80.83view
Maynard Ryan DEVP & CFO 2012-08-07Sell1,700$10.61-80.96view
PAYAN DONALD GEVP, Pres. Discovery&Research 2012-06-19Sell10,000$8.7-76.78view
Flynn James E 2011-05-26Buy650,000$8-74.75view

Press Releases about RIGL :

    Quarterly/Annual Reports about RIGL:

    News about RIGL:

    Articles On GuruFocus.com
    Rigel Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 01 2011 

    More From Other Websites
    RIGEL PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Nov 24 2014
    Rigel Announces Executive Management Changes Nov 24 2014
    7:32 am Rigel Pharma announces retirement of CEO; Raul Rodriguez named CEO and appointed to the... Nov 24 2014
    Rigel Announces Executive Management Changes Nov 24 2014
    RIGEL PHARMACEUTICALS INC Financials Nov 14 2014
    10-Q for Rigel Pharmaceuticals, Inc. Nov 06 2014
    RIGEL PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Nov 04 2014
    RIGEL PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report Nov 04 2014
    Rigel posts 3Q loss Nov 04 2014
    Rigel posts 3Q loss Nov 04 2014
    Rigel Announces Third Quarter 2014 Financial Results Nov 04 2014
    Rigel Announces Third Quarter 2014 Financial Results Nov 04 2014
    Rigel's R348 Fails in Phase II Study, Shares Down 13.6% Aug 14 2014
    Why Rigel Pharmaceuticals (RIGL) Stock Is Declining Today Aug 13 2014
    Rigel eye drug fails mid-stage study, shares fall Aug 13 2014
    RIGEL PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Aug 13 2014
    Rigel experimental eye drug fails mid-stage study Aug 13 2014
    R348 Did Not Meet Endpoints in Phase 2 Dry Eye Study Aug 13 2014
    RIGEL PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 05 2014
    RIGEL PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report Aug 05 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK